As of 12:44:45 PM EST. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Vlad Vitoc M.B.A., M.D. | Co-Founder, President, CEO & Chairman of the Board of Directors | 529.82k | -- | 1970 |
| Mr. Jeffrey C. Himmelreich | Head of Finance | 213.17k | -- | 1975 |
| Dr. Sergei M. Gryaznov Ph.D. | Chief Scientific Officer | 417.33k | -- | 1960 |
| Linda Moreira | Company Secretary | -- | -- | -- |
MAIA Biotechnology, Inc.
444 West Lake Street
Suite 1700
Chicago, IL 60606
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 13
Description
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Corporate Governance
MAIA Biotechnology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
OKYO OKYO Pharma Limited
1.1644
-9.03%
GERN Geron Corporation
3.2850
-3.95%
NLSP NLS Pharmaceutics AG
2.3150
-3.94%
SXTP 60 Degrees Pharmaceuticals, Inc.
0.9800
-10.09%
IMRX Immuneering Corporation
2.1392
+6.96%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4151
+0.05%
NRXP NRx Pharmaceuticals, Inc.
4.7700
+27.01%
SILO Silo Pharma, Inc.
1.9501
+14.04%
CMPX Compass Therapeutics, Inc.
1.7800
-4.30%
QNRX Quoin Pharmaceuticals, Ltd.
0.6424
+3.04%